{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:08:53Z","timestamp":1792267733503,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","award":["DIP-2012-26"],"award-info":[{"award-number":["DIP-2012-26"]}],"id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jcyt.2021.03.005","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T08:38:29Z","timestamp":1620808709000},"page":"833-840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy"],"prefix":"10.1016","volume":"23","author":[{"given":"Zhe Kang","family":"Law","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Jan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Piaw","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Yin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Nur Nafisah","family":"Wan Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Sobri","family":"Muda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozman","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Izhar","family":"Ariff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Azimah","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Keng","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Fadilah","family":"S Abdul Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norlinah","family":"Mohamed Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcyt.2021.03.005_bib0001","first-page":"e38","article-title":"Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jcyt.2021.03.005_bib0002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/hs0102.101990","article-title":"Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project","volume":"33","author":"Morgenstern","year":"2002","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jcyt.2021.03.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104559","article-title":"Case Fatality Decline from 2009 to 2013 among Medicare Beneficiaries with Ischemic Stroke","volume":"29","author":"Man","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10029","key":"10.1016\/j.jcyt.2021.03.005_bib0004","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcyt.2021.03.005_bib0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s001340050625","article-title":"Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care","volume":"24","author":"Berrouschot","year":"1998","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcyt.2021.03.005_bib0006","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000448303","article-title":"Clinical Stroke Syndromes","volume":"40","author":"Kim","year":"2016","journal-title":"Front Neurol Neurosci"},{"key":"10.1016\/j.jcyt.2021.03.005_bib0007","article-title":"Mesenchymal stem cell therapy for ischemic stroke: a look into treatment mechanism and therapeutic potential","author":"Li","year":"2020","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.jcyt.2021.03.005_bib0008","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1474-4422(09)70061-4","article-title":"Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic","volume":"8","author":"Zhang","year":"2009","journal-title":"Lancet neurology"},{"issue":"4","key":"10.1016\/j.jcyt.2021.03.005_bib0009","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/01.STR.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.jcyt.2021.03.005_bib0010","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1161\/STROKEAHA.106.481218","article-title":"One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke","volume":"38","author":"Shen","year":"2007","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jcyt.2021.03.005_bib0011","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/STROKEAHA.111.000326","article-title":"Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke","volume":"44","author":"van Velthoven","year":"2013","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jcyt.2021.03.005_bib0012","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1177\/0271678X18776802","article-title":"The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke","volume":"38","author":"Cunningham","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"10.1016\/j.jcyt.2021.03.005_bib0013","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.RES.0000063425.51108.8D","article-title":"Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats","volume":"92","author":"Chen","year":"2003","journal-title":"Circulation research"},{"issue":"8","key":"10.1016\/j.jcyt.2021.03.005_bib0014","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3727\/096368910X494885","article-title":"Human mesenchymal stromal cells and their derivative, SB623 cells, rescue neural cells via trophic support following in vitro ischemia","volume":"19","author":"Tate","year":"2010","journal-title":"Cell transplantation"},{"issue":"6","key":"10.1016\/j.jcyt.2021.03.005_bib0015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jnr.10691","article-title":"Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat","volume":"73","author":"Chen","year":"2003","journal-title":"Journal of neuroscience research"},{"issue":"3","key":"10.1016\/j.jcyt.2021.03.005_bib0016","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/cmi.2009.28","article-title":"Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells","volume":"6","author":"Liu","year":"2009","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.jcyt.2021.03.005_bib0017","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jcyt.2021.03.005_bib0018","unstructured":"Ministry of Health Malaysia. Malaysian Guidelines for Stem Cell Research and Therapy; 2009. https:\/\/www.crc.gov.my\/wp-content\/uploads\/documents\/MALAYSIAN %20GUIDELINES%20FOR%20STEM%20CELL%20RESEARCH%20AND%20THERAPY%202009%20.pdf [accessed 7th July 2020]"},{"issue":"7","key":"10.1016\/j.jcyt.2021.03.005_bib0019","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3109\/14653249.2011.574118","article-title":"Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy","volume":"13","author":"Chin","year":"2011","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.jcyt.2021.03.005_bib0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12864-020-06868-5","article-title":"Decoding the differentiation of mesenchymal stem cells into mesangial cells at the transcriptomic level","volume":"21","author":"Wong","year":"2020","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.jcyt.2021.03.005_bib0021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/00313020701716367","article-title":"Differentiation of human mesenchymal stem cells into mesangial cells in post-glomerular injury murine model","volume":"40","author":"Wong","year":"2008","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.jcyt.2021.03.005_bib0022","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s13063-017-2341-5","article-title":"Statistical analysis plan for the \u2018Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage\u2019 (TICH-2) trial","volume":"18","author":"Flaherty","year":"2017","journal-title":"Trials"},{"issue":"9968","key":"10.1016\/j.jcyt.2021.03.005_bib0023","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(14)61121-1","article-title":"Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial","volume":"385","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jcyt.2021.03.005_bib0024","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability","volume":"31","author":"Yushkevich","year":"2006","journal-title":"NeuroImage"},{"issue":"6","key":"10.1016\/j.jcyt.2021.03.005_bib0025","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"issue":"Pt 6","key":"10.1016\/j.jcyt.2021.03.005_bib0026","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"Honmou","year":"2011","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jcyt.2021.03.005_bib0027","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s12975-020-00787-z","article-title":"Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke: a Randomized Clinical Trial","volume":"11","author":"Jaillard","year":"2020","journal-title":"Transl Stroke Res"},{"issue":"5","key":"10.1016\/j.jcyt.2021.03.005_bib0028","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/STROKEAHA.118.018287","article-title":"Intravenous Cellular Therapies for Acute Ischemic Stroke","volume":"49","author":"Mays","year":"2018","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.jcyt.2021.03.005_bib0029","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/stem.1808","article-title":"Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia","volume":"32","author":"Tang","year":"2014","journal-title":"Stem Cells"},{"issue":"1-2","key":"10.1016\/j.jcyt.2021.03.005_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jns.2012.01.001","article-title":"Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke","volume":"316","author":"Yu","year":"2012","journal-title":"Journal of the neurological sciences"},{"issue":"3","key":"10.1016\/j.jcyt.2021.03.005_bib0031","doi-asserted-by":"crossref","first-page":"e60049","DOI":"10.1371\/journal.pone.0060049","article-title":"Tracking transplanted bone marrow stem cells and their effects in the rat MCAO stroke model","volume":"8","author":"Goldmacher","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jcyt.2021.03.005_bib0032","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/rme.13.2","article-title":"Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients","volume":"8","author":"Rosado-de-Castro","year":"2013","journal-title":"Regen Med"},{"issue":"6","key":"10.1016\/j.jcyt.2021.03.005_bib0033","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3171\/2008.9.JNS08158","article-title":"Intravenous mesenchymal stem cell therapy for traumatic brain injury","volume":"110","author":"Harting","year":"2009","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.jcyt.2021.03.005_bib0034","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/STROKEAHA.117.018288","article-title":"Intra-Arterial Delivery of Cell Therapies for Stroke","volume":"49","author":"Guzman","year":"2018","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jcyt.2021.03.005_bib0035","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/STROKEAHA.107.502047","article-title":"Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia","volume":"39","author":"Walczak","year":"2008","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jcyt.2021.03.005_bib0036","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/scrt544","article-title":"The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity","volume":"6","author":"Cui","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.jcyt.2021.03.005_bib0037","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00401-017-1667-0","article-title":"Ischemic stroke: experimental models and reality","volume":"133","author":"Sommer","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.03.005_bib0038","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ana.25493","article-title":"Cell therapy for ischemic stroke: are differences in preclinical and clinical study design responsible for the translational loss of efficacy?","volume":"86","author":"Cui","year":"2019","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.jcyt.2021.03.005_bib0039","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1161\/STROKEAHA.119.025436","article-title":"Stem Cells as an Emerging Paradigm in Stroke 4: Advancing and Accelerating Preclinical Research","volume":"50","author":"Boltze","year":"2019","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jcyt.2021.03.005_bib0040","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/STROKEAHA.118.023927","article-title":"Stroke Treatment Academic Industry Roundtable X","volume":"50","author":"Savitz Sean","year":"2019","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jcyt.2021.03.005_bib0041","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/2394-8108.192521","article-title":"Tracking mesenchymal stem cells using magnetic resonance imaging","volume":"2","author":"Rosenberg","year":"2016","journal-title":"Brain Circ"},{"key":"10.1016\/j.jcyt.2021.03.005_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8877003","article-title":"High Dose of Intravenous Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (CLV-100) Infusion Displays Better Immunomodulatory Effect among Healthy Volunteers: A Phase 1 Clinical Study","volume":"2020","author":"Chin","year":"2020","journal-title":"Stem Cells Int"},{"issue":"12","key":"10.1016\/j.jcyt.2021.03.005_bib0043","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/TP.0b013e31821aba18","article-title":"Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells","volume":"91","author":"Wu","year":"2011","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jcyt.2021.03.005_bib0044","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1161\/STROKEAHA.119.026318","article-title":"Phase I\/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke","volume":"50","author":"Levy","year":"2019","journal-title":"Stroke"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921002140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921002140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:35:45Z","timestamp":1778614545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324921002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1465324921002140"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.03.005","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}